Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 12787-12796
Publisher
Informa UK Limited
Online
2020-12-14
DOI
10.2147/ott.s260793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IRAK family in inflammatory autoimmune diseases
- (2020) Lin-Chong Su et al. AUTOIMMUNITY REVIEWS
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells
- (2019) Qing Wei et al. ONCOLOGY RESEARCH
- IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma
- (2018) Bowie Y. Cheng et al. CANCER RESEARCH
- NLRP3 inflammasome: A likely target for the treatment of allergic diseases
- (2018) Yichen Xiao et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The NLRP3 Inflammasome Renders Cell Death Pro-inflammatory
- (2018) Moritz M. Gaidt et al. JOURNAL OF MOLECULAR BIOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy
- (2018) Ghazaleh Kheiri et al. REVIEWS IN THE NEUROSCIENCES
- Cancer secretome and inflammation: The bright and the dark sides of NF-κB
- (2018) Daria Capece et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- An unexpected friend − ROS in apoptosis-induced compensatory proliferation: Implications for regeneration and cancer
- (2018) Neha Diwanji et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy
- (2018) Jack W. Singer et al. Oncotarget
- Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
- (2018) Yun Zhang et al. Frontiers of Medicine
- Role of the NLRP3 inflammasome in cancer
- (2018) Maryam Moossavi et al. Molecular Cancer
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Radiotherapy for Hepatocellular Carcinoma
- (2018) Yao Yu et al. SEMINARS IN RADIATION ONCOLOGY
- Inflammation and cancer
- (2018) Mariko Murata Environmental Health and Preventive Medicine
- Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals
- (2017) Mallenahally Kusha Vidya et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- The NLPR3 inflammasome and obesity-related kidney disease
- (2017) Ben Ke et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis
- (2017) Tong Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The diagnosis and treatment of hepatocellular carcinoma
- (2017) Justin Hartke et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines from 2001 to 2017
- (2017) Peipei Song et al. BioScience Trends
- Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade
- (2017) Guangxi Wang et al. Scientific Reports
- Inflammasome Complexes: Emerging Mechanisms and Effector Functions
- (2016) Vijay A.K. Rathinam et al. CELL
- Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma
- (2016) Ning Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The NLRP3 inflammasome in kidney disease and autoimmunity
- (2016) Holly L Hutton et al. NEPHROLOGY
- Compromised MAPK signaling in human diseases: an update
- (2015) Eun Kyung Kim et al. ARCHIVES OF TOXICOLOGY
- Regulation of inflammasome activation
- (2015) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome
- (2015) Qing Wei et al. LABORATORY INVESTIGATION
- Inflammasomes: mechanism of action, role in disease and therapeutics
- (2015) Haitao Guo et al. NATURE MEDICINE
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Broad targeting of resistance to apoptosis in cancer
- (2015) Ramzi M. Mohammad et al. SEMINARS IN CANCER BIOLOGY
- Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma
- (2015) Yunzhen Gao et al. TUMOR BIOLOGY
- IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
- (2015) Zhen Ning Wee et al. Nature Communications
- Targeting IRAK1 in T-cell acute lymphoblastic leukemia
- (2015) Charles Dussiau et al. Oncotarget
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
- (2013) T. Fernandes-Alnemri et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation